Active Stocks

Fri Jan 16 2026 15:59:57

Kotak Mahindra Bank share price
418.25 -0.65%

Tata Steel share price
188.10 -0.61%

Eternal share price
287.55 -3.89%

NTPC share price
346.25 -0.83%

HDFC Bank share price
931.15 0.56%

Business News > Mint Authors > Neetu Chandra Sharma

Neetu Chandra Sharma

ARTICLES BY NEETU CHANDRA SHARMA

The covid-19 vaccine developed by Bharat Biotech will be the only option for teenagers. (REUTERS)

Centre to supply adequate doses of Covaxin to inoculate 15-18 year olds

2 min read . 29 Dec 2021

MHA in a separate order extended the covid-19 containment measures till 31st January 2022. Mint

MHA seeks states’ ideas to contain Omicron

1 min read . 28 Dec 2021

Citizens aged 60 years or above with comorbidities will be able to access the booster dose through their Co-WIN account.

Health ministry issues guidelines for vaccinating children, booster shots

2 min read . 28 Dec 2021

Crowds gather at the Taj Mahal in Agra on Sunday even as omicron cases continue to see a surge in the country. afp

Indian scientists are studying the Omicron variant: PM Modi

1 min read . 27 Dec 2021

According to the union health ministry data, over 130 of omicron patients have recovered or migrated. (PTI)

India’s Omicron tally reaches 422, states step up preventive measures

2 min read . 27 Dec 2021

Covaxin is already approved in adults and in clinical trials it demonstrated 77.8% efficacy against symptomatic Covid-19 disease and 93.4% against severe symptomatic Covid-19. (REUTERS)

Covaxin receives approval for emergency use in 12-18 years old children

1 min read . 26 Dec 2021

Alert comes a day after WHO warned of a spike in cases amid festival rush

Centre asks states to impose night curfew

3 min read . 25 Dec 2021

Omicron cases up, night curfews in; lockdowns next?

2 min read . 23 Dec 2021

Barely a fortnight away from the year-end, India is far from its stated goal of fully vaccinating its adult population with two doses of a covid vaccine. (HT_PRINT)

Booster shots and jabs for kids will be key challenges in the new year

3 min read . 20 Dec 2021

The Serum Institute has reportedly begun at-risk production of its second Covid-19 vaccine Covavax (Bloomberg)

WHO grants EUL to SII produced Covavax

1 min read . 17 Dec 2021

A swab sample for RT-PCR test is being taken at Meenatai Thackeray Hospital in Nerul on Saturday. (HT_PRINT)

As Omicron cases cross 100, Centre warns against non-essential travel

1 min read . 17 Dec 2021

Covaxin has already received emergency use listing in Vietnam. (REUTERS)

Bharat Biotech to donate 2 lakh doses of covaxin to Vietnam

2 min read . 16 Dec 2021

Implementation of PMKSY approved for for 2021-26

Govt extends PMKSY till FY26 with outlay of ₹93,068 crore

2 min read . 16 Dec 2021

Centre asks states to ensure oxygen supply as omicron cases rise

2 min read . 16 Dec 2021

With fresh Omicron cases erupting from Delhi, Maharashtra and Gujarat, taking the tally to 61, the central government and states strengthened surveillance and testing for the new variant along with the increasing pace of vaccination

Govt wary as WHO confirms Omicron community spread

2 min read . 15 Dec 2021

Adar Poonawalla, chief executive officer, Serum Institute of India.

SII looks to launch Novavax shot for children in 6 months

2 min read . 15 Dec 2021

The researcher said that the results support recent findings in South Africa which highlight Omicron was ‘easy to evade immunity’

Omicron able to evade immunity from jabs, previous infection: study

2 min read . 14 Dec 2021

Dr Balram Bhargava, Director General, ICMR (ANI)

Covid-19: ICMR to study efficacy of Covishield, Covaxin against Omicron

2 min read . 10 Dec 2021

The study was done prior to the emergence of Delta and Omicron, but is said to be potentially applicable to the new Covid variants. (AP)

‘Booster doses may be effective against multiple variants’

2 min read . 10 Dec 2021

The company said that about 2% of the global population is considered at increased risk of an inadequate response to a covid-19 vaccine. In India, this percentage could be a bit higher given the problem of underdiagnosis and ignorance, it said. (REUTERS)

AstraZeneca to submit EUA application for antibody combination Evusheld in India

1 min read . 10 Dec 2021